Affymetrix Inc. and Invitrogen Corporation announced today that Invitrogen has obtained a non-exclusive, worldwide license to a number of Affymetrix patents that will allow Invitrogen to manufacture and sell spotted nucleic acid microarrays in the research field. Financial details of the license were not disclosed. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2763311)